Spatial clustering of amyotrophic lateral sclerosis in Sardinia, Italy: The contribution of age, sex, and genetic factors.


Journal

Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146

Informations de publication

Date de publication:
09 2023
Historique:
revised: 26 06 2023
received: 25 02 2023
accepted: 28 06 2023
medline: 22 8 2023
pubmed: 19 7 2023
entrez: 19 7 2023
Statut: ppublish

Résumé

Several microgeographic clusters of higher/lower incidence of amyotrophic lateral sclerosis (ALS) have been identified worldwide. Differences in the distribution of local factors were proposed to explain the excess ALS risk, whereas the contribution of known genetic/epigenetic factors remains unclear. The aim is to identify restricted areas of higher risk in Sardinia and to assess whether age, sex, and the most common causative genetic mutations in Sardinia (C9orf72 and TARDBP mutations) contributed to the variation in the ALS risk. We performed an ad hoc analysis of the 10-y population-based incident cohort of ALS cases from a recent study of a large Sardinian area. Cluster analysis was performed by age- and sex-adjusted Kulldorff's spatial scan statistic. We identified a statistically significant cluster of higher ALS incidence in a relatively large area including 34 municipalities and >100,000 individuals. The investigated genetic mutations were more frequent in the cluster area than outside. Regardless of the genetic mutations, the excess of ALS risk was significantly associated with either sex or with age ≥ 65 y. Finally, an additive interaction between older age and male sex contributed to the excess of ALS risk in the cluster area but not outside. Our analysis demonstrated that known genetic factors, age, and sex may contribute to microgeographic variation in ALS incidence. The significant additive interaction between older age and male sex we found in the high-incidence cluster could suggest the presence of a third factor connecting the analyzed risk factors.

Identifiants

pubmed: 37466098
doi: 10.1002/mus.27939
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-328

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Goutman SA, Hardiman O, Al-Chalabi A, et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:465-479. doi:10.1016/S1474-4422(21)00414-2
Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108:822-842. doi:10.1016/j.neuron.2020.08.022
Garzillo EM, Miraglia N, Pedata P, Feola D, Lamberti M. Risk agents related to work and amyotrophic lateral sclerosis: an occupational medicine focus. Int J Occup Med Environ Health. 2016;29:355-367. doi:10.13075/ijomeh.1896.00368
Andrew AS, Caller TA, Tandan R, et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener Dis. 2017;17:110-116. doi:10.1159/000453359
Filippini T, Tesauro M, Fiore M, et al. Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case-control study. Int J Environ Res Public Health. 2020;17:2882. doi:10.3390/ijerph17082882
Gunnarsson L-G, Bodin L. Amyotrophic lateral sclerosis and occupational exposures: a systematic literature review and meta-analyses. Int J Environ Res Public Health. 2018;15:2371. doi:10.3390/ijerph15112371
Koeman T, Slottje P, Schouten LJ, et al. Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort. Occup Environ Med. 2017;74:578-585. doi:10.1136/oemed-2016-103780
Nicoletti A, Vasta R, Venti V, et al. The epidemiology of amyotrophic lateral sclerosis in the Mount Etna region: a possible pathogenic role of volcanogenic metals. Eur J Neurol. 2016;23:964-972. doi:10.1111/ene.12973
Caller TA, Doolin JW, Haney JF, et al. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph Lateral Scler. 2009;10(Suppl 2):101-108. doi:10.3109/17482960903278485
Masseret E, Banack S, Boumédiène F, et al. Dietary BMAA exposure in an amyotrophic lateral sclerosis cluster from Southern France. PloS One. 2013;8:e83406. doi:10.1371/journal.pone.0083406
Turabelidze G, Zhu B-P, Schootman M, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998-2002. Neurotoxicology. 2008;29:81-86. doi:10.1016/j.neuro.2007.09.003
Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I. Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995-2004. J Neurol Sci. 2010;298:78-84. doi:10.1016/j.jns.2010.08.004
Boumédiène F, Druet-Cabanac M, Marin B, Preux P-M, Allée P, Couratier P. Contribution of geolocalisation to neuroepidemiological studies: incidence of ALS and environmental factors in Limousin, France. J Neurol Sci. 2011;309:115-122. doi:10.1016/j.jns.2011.07.002
Scott KM, Abhinav K, Stanton BR, et al. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study. Neuroepidemiology. 2009;32:81-88. doi:10.1159/000177032
Borghero G, Pierri V, Vasta R, et al. Incidence of amyotrophic lateral sclerosis in Sardinia, Italy: age-sex interaction and spatial-temporal variability. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:585-591. doi:10.1080/21678421.2022.2041670
Borghero G, Pugliatti M, Marrosu F, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging. 2014;35:2882. doi:10.1016/j.neurobiolaging.2014.07.012
Italian Statistical Institute. www.istat.it
Chio A, Calvo A, Moglia C, Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;82:740-746. doi:10.1136/jnnp.2010.235952
Kulldorff M. A spatial scan statistic. Commun Stat Theory Meth. 1997;26:1848. doi:10.1007/978-3-319-17885-1_101147
Szklo M, Nieto FJ. Epidemiology: beyond the basics. 4th ed. Jones & Bartlett Learning; 2020. doi:10.1249/01.mss.0000617900.65045.1a
Sahai H, Khurshid A. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review. Stat Med. 1996;15:1-21. doi:10.1002/(SICI)1097-0258(19960115)15:1<1::AID-SIM134>3.0.CO;2-E
Chiò A, Moglia C, Canosa A, et al. ALS phenotype is influenced by age, sex, and genetics. Neurology. 2020;94:e802-e810. doi:10.1212/WNL.0000000000008869
Orrù S, Manolakos E, Orrù N, et al. High frequency of the TARDBP p.Ala382Thr mutation in Sardinian patients with amyotrophic lateral sclerosis. Clin Genet. 2012;81:172-178. doi:10.1111/j.1399-0004.2011.01668.x
Pugliatti M, Parish LD, Cossu P, et al. Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009. J Neurol. 2013;260:572-579. doi:10.1007/s00415-012-6681-5
Borghero G, Pugliatti M, Marrosu F, et al. TBK1 is associated with ALS and ALS-FTD in Sardinian patients. Neurobiol Aging. 2016;43:180.e1-180.e5. doi:10.1016/j.neurobiolaging.2016.03.028
Borghero G, Pugliatti M, Marrosu F, et al. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. Neurobiol Aging. 2015;36:2906-2905. doi:10.1016/j.neurobiolaging.2015.06.013

Auteurs

Giuseppe Borghero (G)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.

Maria Margherita Sechi (MM)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Rosario Vasta (R)

Amyotrophic Lateral Sclerosis Center, University of Turin, Turin, Italy.

Vincenzo Pierri (V)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Francesca Pili (F)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.

Ida Pateri (I)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Silvy Pilotto (S)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Tommaso Ercoli (T)

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Antonella Muroni (A)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.

Adriano Chiò (A)

Amyotrophic Lateral Sclerosis Center, University of Turin, Turin, Italy.

Giovanni Defazio (G)

Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Amyotrophic Lateral Sclerosis Center, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH